drugset / Trial / NCT01266174
Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if eltoprazine (as an adjunct to anti-psychotic medication) improves one or more aspects of cognitive impairment in adult schizophrenic patients.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-09
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eltoprazine | Small molecule | 2.5 mg | Oral |
| Subject | Eltoprazine | Small molecule | 5 mg | Oral |
| Subject | Eltoprazine | Small molecule | 7.5 mg | Oral |